
Asrapime 500mg Injection
Marketer
Asrawell Lifecare
Salt Composition
Cefepime (500mg)
Overview Asrapime 500mg Injection
Aximycin 500mg Injection combats bacterial infections. Indicated for severe infections affecting the skin, respiratory system, gastrointestinal tract, urinary system, and bloodstream, it acts by eliminating harmful bacteria. Ineffective against viral infections, Aximycin 500mg Injection is frequently administered to hospitalized patients with critical conditions. Intravenous delivery, either by infusion or direct injection, requires medical supervision. Dosage is tailored to infection type, location, and severity. Complete the prescribed course, even with symptom improvement, as premature cessation may lead to relapse or worsening infection. Potential side effects include rash, pruritus, nausea, emesis, cephalalgia, pyrexia, diarrhea, and localized injection site erythema and edema. These are typically transient, resolving with continued treatment. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, disclose any pre-existing hepatic or renal dysfunction, or antibiotic allergies. Regular blood tests to monitor renal function may be recommended during therapy. Generally considered safe for pregnant and breastfeeding individuals under medical guidance.
Uses of Asrapime 500mg Injection
Managing life-threatening bacterial infections
Major Benefits of Asrapime 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Asrapime 500mg Injection:
- Injection site reactions (pain, swelling, redness)
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
- Increased prothrombin time
- Decreased phosphate level in blood
- Increased partial thromboplastin time (PTT)
How to use Asrapime 500mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
How Asrapime 500mg Injection works:
Asrapime 500mg injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, a process essential for bacterial viability.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Asrapime 500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Asrapime 500mg is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or absent negative consequences for fetal development; nonetheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Asrapime 500mg Injection is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing minimal risk to the infant. However, extended Asrapime 500mg Injection use should be avoided due to potential side effects including skin rashes and diarrhea.
DrivingCONSULT YOUR DOCTOR
Asrapime 500mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Asrapime 500mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Asrapime 500mg Injection appears safe for use in individuals with hepatic impairment. Preliminary findings indicate that dose modification may be unnecessary for this population. Physician consultation is recommended.
What if you forget to take Asrapime 500mg Injection :
Omit a dose of Asrapime 500mg Injection? Seek your physician's advice.
Facts to Know About Asrapime 500mg Injection
| Label | Value |
|---|---|
| Pharmaceutical Category | Cephalosporins of the third and fourth generations, possessing wide-ranging antimicrobial activity. |
| Potential for Dependence | None. |
| Type of Medication | Agents against infection |
| Mechanism of Action | Fourth-generation cephalosporin antibiotics. |
